25 results on '"Sánchez, Laura"'
Search Results
2. FRI-472-YI Mitochondrial metabolism is disrupted by ciprofloxacin preventing cholangiocarcinoma cell proliferation
3. WED-271 Circulating vesicle microRNAs for metabolic dysfunction-associated steatotic liver disease (MASLD) staging and progression towards liver cancer
4. OS-076-YI Bile extracellular vesicles hold protein biomarkers for the early diagnosis of cholangiocarcinoma in individuals with primary sclerosing cholangitis
5. OS-042-YI Metabolic reprogramming induced by pravastatin prevents polycystic liver disease progression improving mitochondrial bioenergetics in cystic cholangiocytes
6. Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
7. Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease
8. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by inhibiting multi-organ bile acid transport and shows translational relevance to human
9. Role of TGR5 in fat-to-liver communication during NAFLD
10. Circulating vesicles hold etiology-related protein biomarkers of cholangiocarcinoma risk, early diagnosis and prognosis mirroring tumour cells
11. Presence of cirrhosis in chronic liver disease patients associates with a lower immune response to COVID-19 vaccines-a multicenter european study
12. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
13. Metabolic NAFLD subtypes align with cardiovascular and genetic risk factors
14. SAT-159-YI Mitochondrial integrity and auto (mito)phagy are disrupted in experimental models of primary biliary cholangitis, contributing to disease pathogenesis
15. WED-558 Inhibition of miR-21 improves muscle activity in experimental metabolic dysfunction-associated steatotic liver disease
16. WED-397 - Role of TGR5 in fat-to-liver communication during NAFLD
17. SAT-468 - Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease
18. SAT-238 - Liquid biopsy protein biomarkers of cholangiocarcinoma risk, early diagnosis and survival mirroring tumor cells
19. OS-074-YI - A3907, a systemic ASBT inhibitor, improves cholestasis in mice by inhibiting multi-organ bile acid transport and shows translational relevance to human
20. ZEB1 promotes cholangiocarcinoma progression through tumor dedifferentiation and paracrine signaling between tumor cells and cancer-associated fibroblasts
21. Proteostasis improvement in cystic cholangiocytes alleviates endoplasmic reticulum stress and halts polycystic liver disease
22. SAT-485-European cliolangiocarcinoma (EU-CCA) registry: An initiative to broaden awareness on the second most common primary liver cancer
23. PS-011-New synthetic conjugates of ursodeoxycholic acid inhibit hepatorenal cystogenesis in experimental models of polycystic liver disease
24. FRI277 - Proteostasis improvement in cystic cholangiocytes alleviates endoplasmic reticulum stress and halts polycystic liver disease.
25. FRI490 - ZEB1 promotes cholangiocarcinoma progression through tumor dedifferentiation and paracrine signaling between tumor cells and cancer-associated fibroblasts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.